# III. Market Structure and Value Capture 20260112.docx

# III. Market Structure and Value Capture







III.1. Global Animal Demographics and Trends



The global animal health market is currently undergoing a profound structural shift characterized by a "two-speed" dynamic. In the Companion Animal sector, the "pet humanization" trend is driving a shift from volume to value, where owners perceive animals as integral family members. Conversely, the Livestock and Aquaculture sectors are navigating a great divergence: a structural contraction in Western herds driven by policy and climate, contrasted with the relentless expansion of poultry and aquaculture globally to meet protein demand.



III.1.1. Companion Animals (Pets): Regional Dynamics



The global pet population is estimated to include over 1 billion individuals. Developed nations are prioritizing longevity and wellness, while emerging markets are experiencing rapid volume expansion driven by urbanization.



III.1.1.1. North America: The Value Leader 



The United States remains the global bellwether. As of the 2025 APPA Survey, approximately 94 million households (71%) own a pet, demonstrating resilience against economic headwinds.

The Shift to Felines: While dogs remain popular (68 million households), the cat population is accelerating, reaching 49 million households in 2025.

Generational Change: Gen Z is now the fastest-growing cohort (20%) and is driving the "multispecies" trend, owning both dogs and cats simultaneously.





[INSERT FIGURE: Household Pet Ownership Rate (2023)] Data points: US (71%), Mexico (70%), Europe (49%), UK ??





III.1.1.2. European Union: The Cat Continent



Europe represents a highly diverse, cat-dominant market. According to FEDIAF 2025 data, the total pet population reached 281.5 million.

Feline Dominance: The European population includes approximately 127 million cats compared to 104 million dogs.

Growth Divergence: the trendlines for 2018–2023 show a divergence: while the dog population has grown modestly by +5%, the cat population has surged by +11%, reflecting the shift toward smaller, apartment-friendly animals.

[INSERT FIGURE: Pet Population in Europe by Species (2023)] Data points: Cats (127M), Dogs (104M), others !!

[INSERT FIGURE: Growth of Cat and Dog Populations in Europe (2018–2023)] Data points: Cats (+11%), Dogs (+5%).



III.1.1.3. Asia-Pacific & Latin America: the growth engines



APAC is the engine of volume growth, characterized by rapid urbanization and the "replacement child" phenomenon.



China's "Cat Economy": In a historic shift, cats overtook dogs in China in 2024 (71.5 million cats vs. 52.6 million dogs), driven by the demanding "996" work culture which favors independent pets.

Latin America: Mexico boasts high ownership rates (70% of households), historically dog-centric, but with a cat population that exploded by 41% between 2017 and 2022.





III.1.1.4. Latin America (The High-Growth Engine)



LATAM markets, particularly Brazil and Mexico, are expanding through volume and increased caloric conversion (the move from table scraps to commercial feed).

Brazil: The world’s third-largest pet market with over 160 million pets, including 60 million dogs and a rapidly growing cat population (30 million).

Mexico: High ownership rates (70% of households) are historically dog-centric, but the cat population exploded by 41% between 2017 and 2022, signaling a rapid modernization of the sector.





### III.1.2. Livestock Headcounts: The "Great Divergence"

The industrial livestock and aquaculture sectors are navigating a complex landscape defined by the "Great Divergence": a structural contraction in Western herds (EU, US) driven by policy and climate, contrasted with the relentless expansion of poultry and aquaculture globally. In 2024, the largest livestock segment by specialty feed additive revenue was poultry. Within the specific "Feed Probiotics" category, Poultry accounts for 60% of global volume, followed by Swine (25%), Ruminants (10%), and Aquaculture (5%). Conversely, the US cattle inventory hit a 73-year low, and the EU pig herd continues a decade-long decline. These trends highlight a decoupling of protein production from traditional agrarian land use.

[INSERT FIGURE: Feed Probiotics Market Share by Species (2024)] Data points: Poultry (60%), Swine (25%), Ruminant (10%), Aqua (5%).

Poultry: The Engine of Growth

Poultry remains the primary driver of global meat production, which rose by 1.3% to 365 million tonnes in 2024. The sector's dominance is evidenced by its 43.5% share of the global feed additives market, valued at USD 15.72 billion in 2024. However, this expansion faces the "viral constraint" of Highly Pathogenic Avian Influenza (HPAI). Between 2005 and 2024, HPAI caused the loss of over 633 million poultry globally.



Swine & Cattle: Structural Contraction in the West

The swine sector is characterized by contraction in the West and volatility in Asia.

European Union: The EU pig population fell to 132 million in 2024, a 0.5% annual drop and an 8.1% decline compared to 2014, driven by nitrogen limits and input costs.

Global Dynamics: While African Swine Fever (ASF) continues to disrupt herds in regions like China, import demand has softened due to domestic herd recovery.

[INSERT FIGURE: Indexed Livestock Segment Trends in Europe (2018–2023)]



Cattle: Historic Liquidations

United States: The US cattle inventory collapsed to 87.2 million head on January 1, 2024, the lowest level since 1951. Heifer retention fell to 4.86 million (-1%), indicating herd rebuilding has not begun.

European Union: The EU bovine population dropped to 72 million in 2024, a 2.8% decrease from the previous year and an 8.7% decline over the last decade.

Small Ruminants: A North-South Divide In the West, small ruminant sectors are shrinking (EU sheep -9.4%). In contrast, global numbers remain stable, supported by extensive systems in the Global South.

3. Regional Spotlight: Indexed Trends The following table visualizes the divergent trajectories in Europe, highlighting the "de-ruminization" of the continent.

[INSERT FIGURE: Indexed Livestock Segment Trends in Europe (2018–2023)]

Table 1: Indexed Trends (Baseline 2018 = 100)

Poultry: 110.5 (Growth)

Bovine: 94.8 (Decline)

Pigs: 91.1 (Decline)

Sheep/Goats: 89.5 (Decline)

Data Source: Table 1 below.

### 

### IV.1.3. Aquaculture: The "Blue Transformation"



The Great Overtaking In a historic shift, the farmed production of aquatic animals reached 94.4 million tonnes in 2022, surpassing the 92.3 million tonnes harvested from capture fisheries. Total aquaculture production hit a record 130.9 million tonnes. Asia remains the dominant force, accounting for 91.4% of global production.

Species Diversification To mitigate biological risks associated with monocultures (e.g., salmon sea lice), the industry is diversifying. Emerging species like Mangrove Red Snapper and Seriola (Yellowtail) are gaining traction. The FAO's "Blue Transformation" strategy underpins this growth, focusing on alternative feeds to decouple production from wild forage fish.

### III.1.4. Intensification and Stress Landscapes

Meeting global demand requires high-density systems that push animals to their physiological limits, creating distinct "stress landscapes" that drive nutraceutical adoption.

Physiological Cost: High metabolic rates lead to oxidative stress and Reactive Oxygen Species (ROS), damaging tissues.

Heat Stress: Rising global temperatures cause "leaky gut" in cattle/swine and "oxygen squeeze" in aquaculture.

The Paradox of Precision: Precision Livestock Farming (PLF) tools manage massive herds but may entrench intensive practices that cause stress.





III.2. Urbanization and Decision Pathways



III.2.1. The Impact of Urbanization on Format Preferences



Urbanization correlates with smaller living spaces and smaller pets, which fundamentally changes administration preferences. Data on "Nutraceutical Format Popularity" reveals a stark species-specific split:

Dogs: Dominated by Soft Chews (39%) and Treats (25%). Urban owners treat supplements as a "bonding moment," necessitating high palatability.

Cats: High rejection of solid pills drives the market toward Liquids/Pastes (35%) and Powders (30%) that can be mixed invisibly into wet food.

Horses: Administration differs completely, favoring Powders/Pellets (60%) for feed top-dressing and Oral Syringes (20%) for acute performance dosing.

[INSERT FIGURE: What formats are the most popular and for which species] Data points: Dog (Chews 39%), Cat (Liquids 35%), Horse (Powders 60%).





III.2.2. Functional Feed Focus: The Probiotics Market



Within the livestock sector, the decision pathway is driven by ROI and antibiotic reduction. Feed Probiotics represent a high-growth proxy for this trend. In 2024, Poultry remained the dominant consumer, accounting for 60% of global volume. Swine followed at 25% (driven by post-weaning health), while Ruminants (10%) and Aquaculture (5%) represent emerging frontiers.



[INSERT FIGURE: Feed Probiotics Market Share by Species (2024)] Data points: Poultry (60%), Swine (25%), Ruminant (10%), Aqua (5%).





III.3. The Economics of Care: WTP and Wallet Share



III.3.1. The Preventive Health Wallet 



The "Pet Humanization" trend has reshaped how owners allocate disposable income. Breaking down the "Preventive Health Wallet" for a typical proactive pet owner reveals that while Food remains the base (45%), the "Wellness Stack" has expanded. Veterinary Care accounts for 30%, but significantly, Nutraceuticals & Supplements now capture 15% of the wallet—surpassing Toys & Accessories (10%). This shift indicates that owners are prioritizing longevity over entertainment.

[INSERT FIGURE: Preventive Health Wallet Breakdown] Data points: Food (45%), Vet (30%), Supplements (15%), Toys (10%).



III.3.2. Consumer Segmentation and Psychological Drivers



Not all owners spend equally. Analysis identifies three distinct archetypes:

The "Spare No Expense" Parent (20% of market): High income, inelastic WTP. They drive the premium supplement market (e.g., $80+ CBD oils).

The "Value-Conscious" Owner (50%): Seeks ROI; buys multivitamins and mid-range functional treats.

The "Basic Care" Keeper (30%): Focuses on core vaccinations only; low adoption.



[INSERT FIGURE: Consumer Segmentation by WTP] Data points: Spare No Expense (20%), Value (50%), Basic (30%).



Psychological Factors The "Psychological Factors Influencing WTP" are heavily weighted toward negative emotion avoidance:

Fear of Loss / Future Regret (40% impact): The strongest driver (e.g., avoiding future arthritis).

Anthropomorphism (30%): "If I take vitamins, my dog should too."

Perceived Veterinarian Endorsement (20%): Validation justifies the price.

Social Signaling (10%): Premium branding.

[INSERT FIGURE: Psychological Factors Influencing the WTP] Data points: Fear (40%), Anthropomorphism (30%), Vet Rec (20%), Social (10%).





III.4. The Longevity Economy: The "Greying" Pet Population



As veterinary care improves, pets are living longer, creating a "demographic tsunami" of senior animals. This aging cohort is the single largest value driver for veterinary nutraceuticals, transforming the market from "growth" (puppy/kitten) to "maintenance and repair" (geriatric).





III.4.1. The Statistics of Aging



The Demographic Value Multiplier.

The addressable market for chronic care is expanding:

United States: The share of owners with a senior dog (age 7+) reached 52% in 2024. Senior cats rose to 54%.

Europe: Senior pets comprise approximately 30% of the population. Preventive testing reveals underlying health conditions in 33% of apparently healthy senior cats.



III.4.2. Chronic Care Revenue Opportunities

Joint & Mobility (The Apex Segment): Osteoarthritis is the #1 condition for senior pets. Mobility supplements command 31.2% of the market share. The value driver is the shift from generic Glucosamine to premium ingredients like UC-II Collagen and Green-Lipped Mussel.

Cognitive Dysfunction (CDS): As dogs live past 12 years, "doggy dementia" is becoming a prevalent concern. Targeted interventions (MCTs, antioxidants) are creating a new premium category.

The "Pre-Senior" Expansion: Brands are successfully expanding the "Senior" category downwards to pets aged 5–7 ("Preventive Wellness"), extending the Customer Lifetime Value (CLV) by 2–3 years.





https://healthforanimals.org/reports/pet-care-report/global-trends-in-the-pet-population/

https://www.petfoodindustry.com/pet-ownership-statistics/article/15747936/chart-cats-and-dogs-lead-us-pet-ownership-growth-20232025

https://americanpetproducts.org/news/the-american-pet-products-association-appa-releases-2025-dog-cat-report

https://www.petfoodindustry.com/pet-ownership-statistics/article/15747936/chart-cats-and-dogs-lead-us-pet-ownership-growth-20232025

https://www.petfoodindustry.com/pet-ownership-statistics/article/15747936/chart-cats-and-dogs-lead-us-pet-ownership-growth-20232025

Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2023

Annual Report and Accounts for the year ended 30 June 2023

Nicotra, Mario, Tommaso Iannitti, and Alessandro Di Cerbo. "Nutraceuticals, Social Interaction, and Psychophysiological Influence on Pet Health and Well-Being: Focus on Dogs and Cats." Veterinary Sciences 12.10 (2025): 964.

FEDIAF-Facts-Figures-2025.pdf



### Bibliography & Data Sources

American Pet Products Association (APPA). "2025 National Pet Owners Survey."

FEDIAF. "Facts & Figures 2025 (European Pet Food Industry)."

Eurostat. "Agricultural production - livestock and meat (2018-2023)."

FAO. "The State of World Fisheries and Aquaculture (SOFIA) 2024."

Dechra Pharmaceuticals PLC. "Annual Report 2023."

Mordor Intelligence. "Global Veterinary Animal Healthcare Market 2024-2030."

Packaged Facts. "Pet Supplements in the US, 10th Edition."

Nicotra, M., et al. (2025). "Nutraceuticals... Influence on Pet Health." Veterinary Sciences.

Rahman, M., et al. (2022). "Insights in... alternatives to antibiotic growth promoters." Antibiotics







  Figure: Household Pet Ownership Rate (2023) -> Use the percentages in IV.1.1 (US 71%, EU 49%, Mexico 70%).

  Figure: Growth of Cat and Dog Populations in Europe (2018–2023) -> Use the text in IV.1.2 (+11% Cats vs +5% Dogs).

  Figure: Pet Population in Europe by Species (2023) -> Use IV.1.2 (127M Cats, 104M Dogs).

  Figure: Indexed Livestock Segment Trends in Europe -> Use Table 1 provided in your draft.

  Figure: Feed Probiotics Market Share by Species (2024) -> Use the new text in IV.2.X (Poultry 60%, Swine 25%, Ruminant 10%, Aqua 5%).

  Figure: Preventive Health Wallet Breakdown -> Use IV.3.1 (Food 45%, Vet 30%, Supplements 15%, Toys 10%).

  Figure: Psychological Factors Influencing WTP -> Use IV.3.3 (Fear 40%, Anthropomorphism 30%, Vet 20%, Social 10%).

  Figure: Consumer Segmentation by WTP -> Use IV.3.2 (Spare No Expense 20%, Value 50%, Basic 30%).

  Figure: What formats are the most popular -> Use the text in IV.2 (Dog: Chews 39%; Cat: Liquid/Paste 35%; Horse: Powder 60%).















Table 1: Indexed Livestock Segment Trends in Europe (2018–2023)

Baseline: 2018 = 100 (Derived from Eurostat Data )   



6. Conclusion

The 2024 demographic data confirms a bi-modal future for animal protein. On one side, terrestrial livestock in the West is contracting (-8.7% EU cattle, -8.1% EU pigs) due to sustainability pressures and climate volatility. On the other, poultry (+1.3% global output) and aquaculture (surpassing capture fisheries) continue to scale industrially. Future resilience will depend on managing the intense biological pressures of these high-density systems, specifically through disease control (HPAI vaccination), stress mitigation (antioxidants, climate control), and the successful diversification of aquatic species.







https://www.mordorintelligence.com/industry-reports/global-veterinary-animal-healthcare-market-industry

https://www.mordorintelligence.com/industry-reports/global-veterinary-animal-healthcare-market-industry

https://www.polarismarketresearch.com/industry-analysis/specialty-feed-additives-market

Sources: Packaged Facts via Nutritional Outlook (2018 supplement market $636M); Makers Nutrition/Packaged Facts (2019 supplements $1.9B); Packaged Facts report 2024 (supplements >$2.7B)[11]; PetfoodIndustry/Packaged Facts (pet food ~$27B in 2018, ~$58B in 2022)[5][13]; APPA State of Industry 2025[8][9].

Rahman, Md Ramim Tanver, Ismail Fliss, and Eric Biron. "Insights in the development and uses of alternatives to antibiotic growth promoters in poultry and swine production." Antibiotics 11.6 (2022): 766.

https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Agricultural_production_-_livestock_and_meat

https://www.mordorintelligence.com/industry-reports/global-feed-additives-market-industry

Akinyemi, Fisayo, and Deborah Adewole. "Environmental stress in chickens and the potential effectiveness of dietary vitamin supplementation." Frontiers in Animal Science 2 (2021): 775311.



OECD-FAO AGRICULTURAL OUTLOOK 2025-2034 © OECD/FAO 2025



















III.4. The Value Chain: From Molecule to Market



The veterinary nutraceutical value chain is bifurcated. While the upstream (ingredients) is shared, the downstream diverges into two distinct economic models: the High-Velocity Consumer Model (Pet) and the Technical Integration Model (Livestock). Understanding who captures the margin is critical for investment thesis.



III.4.1. Upstream: Raw Materials and CDMOs (The Foundation)

1. Ingredient Suppliers (The Commodity vs. IP Split)

Commodities: 70–80% of vitamins and amino acids originate from China. Margins here are thin (10–15% EBITDA) and volatile, driven by supply chain shocks.

Branded Active Ingredients: Companies holding IP on specific strains (e.g., Bacillus subtilis variants) or extraction methods (e.g., UC-II Collagen) command premium pricing. They do not sell "powder"; they sell "clinical claims."

Concentration: The top 5 global players (e.g., DSM-Firmenich, Kemin, Adisseo) control the majority of the high-value IP landscape.

2. CDMOs (Contract Development & Manufacturing Organizations) The "Hidden Engine" of the industry. In the Pet sector, >60% of brands do not manufacture their own products. They rely on CDMOs (like Vetio or Captek) for formulation and extrusion (Soft Chews).

Value Add: CDMOs capture margin by solving the "Palatability Puzzle." A brand pays a premium for a soft chew matrix that guarantees a dog will eat it, as this drives repeat purchase rates.

[INSERT FIGURE: Mapping of the different actors in the nutraceutical development, vertical integration flow] Visual Note: Show flow from Raw Material -> CDMO/Premixer -> Brand Owner -> Distributor -> End User.



III.4.2. Downstream Divergence: Who Captures the Margin?

A. The Pet "Wellness" Chain (B2C) This model mirrors the Human Supplement industry.

The "Vet-Ex" Erosion: Historically, sales went through veterinarians (high trust, high markup). Today, the channel mix has flipped. E-commerce (Amazon, Chewy) and DTC now capture >50% of volume, bypassing the 40-50% markup charged by clinics.

Direct-to-Consumer (DTC) Power: Brands like Zesty Paws or YuMOVE operate with Gross Margins of 60–70%. By owning the customer data, they reduce Customer Acquisition Costs (CAC) and increase Lifetime Value (LTV).

B. The Livestock "Efficiency" Chain (B2B) This model mirrors the Ag-Tech industry.

The Premix Bottleneck: Farmers rarely buy pure ingredients. They buy "Premixes" (blends of vitamins, minerals, and enzymes). The Premixer (e.g., Trouw Nutrition, Cargill) acts as the gatekeeper.

Service over Product: In this chain, value is captured not by the product alone, but by the service wrapper (Nutritional Analysis, Digital Monitoring). Margins are lower (10–15% EBITDA), but volume is massive, and switching costs for farmers are high.

[INSERT FIGURE: Waterfall Value Breakdown in the pet and livestock supplement chain] Data for Chart Construction:

Pet Supplement ($50 Retail Price): COGS ($10) -> Packaging/Logistics ($5) -> Marketing/CAC ($15) -> Brand Margin ($20).

Livestock Additive ($50 Cost to Farmer): Raw Material ($25) -> Manufacturing/Blending ($10) -> Tech Support/Sales ($10) -> Integrator Margin ($5).



III.4.3. Financial Performance: Margin Profiles

The industry presents a "Risk/Reward" spectrum regarding profitability.

Pure-Play Pet Brands: High EBITDA (20–25%) but high risk due to low barriers to entry and high marketing spend.

Science-Based Ingredient Suppliers: Very High EBITDA (25–30%) due to IP protection and recurring B2B revenue.

Livestock Integrators: Moderate EBITDA (8–12%) but extremely stable cash flows due to essential nature of food production.

[INSERT FIGURE: Margin vs market size / EBITDA margins by segment] Data points: Ingredient Suppliers (30%), Pet Brands (25%), CDMOs (18%), Livestock Premixers (12%).



III.4.4. Integration Models: The "Pharma" Encroachment

Why are pharmaceutical giants buying nutraceuticals?

The Strategy: Companies like Zoetis and Elanco are vertically integrating. By acquiring nutraceutical brands (e.g., Zoetis acquiring Platinum Performance), they capture the animal before it gets sick.

The Funnel: Nutraceuticals serve as the "Entry Funnel." A pet owner starts with a joint supplement; as the disease progresses, the same company cross-sells the prescription NSAID (e.g., Rimadyl).



Bibliography & Data Sources for Part III.4

Bain & Company. "Pet Care: The new era of value creation (2024)."

L.E.K. Consulting. "Pet Nutraceuticals: Opportunities in a booming market."

Grand View Research. "Animal Health Market Size & Share Analysis Report, 2030."

Zoetis Inc. "Investor Presentations (Acquisition Strategy)."

Internal Analysis based on Public Comparable Companies (Idexx, Dechra, DSM).

